NCT01738139 2024-03-21Ipilimumab and Imatinib Mesylate in Advanced CancerM.D. Anderson Cancer CenterPhase 1 Completed68 enrolled
NCT00025415 2013-02-07Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionNational Cancer Institute (NCI)Phase 1 Completed60 enrolled